161 related articles for article (PubMed ID: 29264937)
1. Rationale and design of the IMPACT EU-trial: improve management of heart failure with procalcitonin biomarkers in cardiology (BIC)-18.
Möckel M; Slagman A; Vollert JO; Ebmeyer S; Wiemer JC; Searle J; Giannitsis E; Kellum JA; Maisel A
Biomarkers; 2018 Feb; 23(1):97-103. PubMed ID: 29264937
[TBL] [Abstract][Full Text] [Related]
2. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
[TBL] [Abstract][Full Text] [Related]
3. Improve Management of acute heart failure with ProcAlCiTonin in EUrope: results of the randomized clinical trial IMPACT EU Biomarkers in Cardiology (BIC) 18.
Möckel M; de Boer RA; Slagman AC; von Haehling S; Schou M; Vollert JO; Wiemer JC; Ebmeyer S; Martín-Sánchez FJ; Maisel AS; Giannitsis E
Eur J Heart Fail; 2020 Feb; 22(2):267-275. PubMed ID: 31833168
[TBL] [Abstract][Full Text] [Related]
4. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial.
Schuetz P; Kutz A; Grolimund E; Haubitz S; Demann D; Vögeli A; Hitz F; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Marlowe RJ; Zimmerli W; Mueller B;
Int J Cardiol; 2014 Aug; 175(3):464-72. PubMed ID: 25005339
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin in heart failure: hic et nunc.
Cvetinovic N; Isakovic AM; Lainscak M; Dungen HD; Nikolic NM; Loncar G
Biomark Med; 2017 Oct; 11(10):893-903. PubMed ID: 28976777
[TBL] [Abstract][Full Text] [Related]
6. Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study).
van der Does Y; Limper M; Jie KE; Schuit SCE; Jansen H; Pernot N; van Rosmalen J; Poley MJ; Ramakers C; Patka P; van Gorp ECM; Rood PPM
Clin Microbiol Infect; 2018 Dec; 24(12):1282-1289. PubMed ID: 29870855
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin and long-term prognosis after an admission for acute heart failure.
Villanueva MP; Mollar A; Palau P; Carratalá A; Núñez E; Santas E; Bodí V; Chorro FJ; Miñana G; Blasco ML; Sanchis J; Núñez J
Eur J Intern Med; 2015 Jan; 26(1):42-8. PubMed ID: 25592074
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: a randomized controlled trial.
Maravić-Stojković V; Lausević-Vuk L; Jović M; Ranković A; Borzanović M; Marinković J
Srp Arh Celok Lek; 2011; 139(11-12):736-42. PubMed ID: 22338468
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and Prognostic Utility of Procalcitonin in Patients Presenting to the Emergency Department with Dyspnea.
Alba GA; Truong QA; Gaggin HK; Gandhi PU; De Berardinis B; Magrini L; Bajwa EK; Di Somma S; Januzzi JL;
Am J Med; 2016 Jan; 129(1):96-104.e7. PubMed ID: 26169892
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.
Schuetz P; Christ-Crain M; Wolbers M; Schild U; Thomann R; Falconnier C; Widmer I; Neidert S; Blum CA; Schönenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Müller B;
BMC Health Serv Res; 2007 Jul; 7():102. PubMed ID: 17615073
[TBL] [Abstract][Full Text] [Related]
12. MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit.
Heining L; Giesa C; Ewig S
Lung; 2016 Apr; 194(2):185-91. PubMed ID: 26748496
[TBL] [Abstract][Full Text] [Related]
13. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial.
Stocker M; Fontana M; El Helou S; Wegscheider K; Berger TM
Neonatology; 2010; 97(2):165-74. PubMed ID: 19776651
[TBL] [Abstract][Full Text] [Related]
14. Procalcitonin-guided therapy for the initiation of antibiotics in the ED: a systematic review.
van der Does Y; Rood PP; Haagsma JA; Patka P; van Gorp EC; Limper M
Am J Emerg Med; 2016 Jul; 34(7):1286-93. PubMed ID: 27130585
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
[TBL] [Abstract][Full Text] [Related]
16. Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
Maisel A; Neath SX; Landsberg J; Mueller C; Nowak RM; Peacock WF; Ponikowski P; Möckel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng LL; Daniels LB; Christenson RH; Potocki M; McCord J; Terracciano G; Hartmann O; Bergmann A; Morgenthaler NG; Anker SD
Eur J Heart Fail; 2012 Mar; 14(3):278-86. PubMed ID: 22302662
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients.
Cinar O; Cevik E; Acar A; Kaya C; Ardic S; Comert B; Yokusoglu M; Bilgi C; Meisner M; Madsen T
Am J Emerg Med; 2012 Nov; 30(9):1915-20. PubMed ID: 22742951
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin guided antibiotic therapy of acute exacerbations of asthma: a randomized controlled trial.
Tang J; Long W; Yan L; Zhang Y; Xie J; Lu G; Yang C
BMC Infect Dis; 2013 Dec; 13():596. PubMed ID: 24341820
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin-guided antibiotic treatment in heart failure.
Sandek A; Springer J; Habedank D; Brunkhorst F; Anker SD
Lancet; 2004 May; 363(9420):1555; author reply 1555-6. PubMed ID: 15135615
[No Abstract] [Full Text] [Related]
20. Personalized CHF treatment: PCT to guide therapy in heart failure patients.
Lee NS; Daniels LB
Int J Cardiol; 2014 Sep; 176(2):307-8. PubMed ID: 25115245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]